Knight Therapeutics, Inc. (GUD.TO)
10.83
+0.10
(+0.93%)
CAD |
TSX |
Oct 09, 16:00
Knight Therapeutics Price : 10.83 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 10.66 | 11.00 | 10.40 | 10.83 | 76841.00 |
| Oct 08, 2026 | 10.73 | 10.82 | 10.64 | 10.73 | 49185.00 |
| Oct 07, 2026 | 10.31 | 10.79 | 10.31 | 10.71 | 61370.00 |
| Oct 06, 2026 | 10.41 | 10.57 | 10.37 | 10.54 | 68150.00 |
| Oct 05, 2026 | 10.34 | 10.36 | 10.21 | 10.36 | 64251.00 |
| Oct 02, 2026 | 10.67 | 10.80 | 10.31 | 10.32 | 63813.00 |
| Oct 01, 2026 | 10.60 | 10.64 | 10.47 | 10.64 | 56248.00 |
| Sep 30, 2026 | 10.35 | 10.74 | 10.28 | 10.59 | 118770.0 |
| Sep 29, 2026 | 10.20 | 10.41 | 10.16 | 10.35 | 53806.00 |
| Sep 28, 2026 | 10.24 | 10.30 | 10.18 | 10.27 | 34513.00 |
| Sep 25, 2026 | 10.24 | 10.29 | 10.10 | 10.29 | 60870.00 |
| Sep 24, 2026 | 10.04 | 10.17 | 10.01 | 10.10 | 57556.00 |
| Sep 23, 2026 | 10.29 | 10.29 | 10.01 | 10.09 | 80185.00 |
| Sep 22, 2026 | 10.24 | 10.37 | 10.18 | 10.29 | 137369.0 |
| Sep 21, 2026 | 10.26 | 10.26 | 10.15 | 10.18 | 63313.00 |
| Sep 18, 2026 | 10.25 | 10.27 | 10.10 | 10.25 | 59696.00 |
| Sep 17, 2026 | 10.07 | 10.34 | 10.06 | 10.23 | 57613.00 |
| Sep 16, 2026 | 9.99 | 10.15 | 9.86 | 10.01 | 74380.00 |
| Sep 15, 2026 | 9.97 | 10.11 | 9.89 | 9.96 | 45286.00 |
| Sep 14, 2026 | 9.89 | 10.09 | 9.85 | 10.02 | 57025.00 |
| Sep 11, 2026 | 9.75 | 9.86 | 9.74 | 9.85 | 197509.0 |
| Sep 10, 2026 | 9.88 | 9.93 | 9.65 | 9.73 | 82049.00 |
| Sep 09, 2026 | 9.88 | 9.94 | 9.86 | 9.90 | 42211.00 |
| Sep 08, 2026 | 9.90 | 9.94 | 9.80 | 9.90 | 40411.00 |
| Sep 04, 2026 | 9.95 | 10.05 | 9.85 | 10.01 | 44902.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 4.09 |
| Bausch Health Cos., Inc. | 8.64 |
| Cipher Pharmaceuticals, Inc. | 13.65 |
| BioSyent, Inc. | 17.15 |
| Revive Therapeutics Ltd. | 0.025 |
Price Related Metrics
| PE Ratio | 72.10 |
| PS Ratio | 1.959 |
| PEG Ratio | 0.0157 |
| Price to Book Value | 1.332 |
| Price to Free Cash Flow | 10.83 |
| Earnings Yield | 1.39% |
| Market Cap | 1.064B |
| PEGY Ratio | 0.0157 |
| Operating PE Ratio | 40.62 |
| Normalized PE Ratio | 53.46 |